Encorafenib, binimetinib, and cetuximab combination therapy for patients with BRAF V600E mutant colorectal cancer

被引：0
|
作者：
Moro, Kazuki [1 ,2 ]
Saiki, Takuro [1 ]
Sasaki, Kenta [1 ]
Matsumoto, Akio [2 ]
Zhou, Qiliang [1 ]
Nakano, Mae [2 ]
Nakano, Masato [2 ]
Matsumoto, Yoshifumi [1 ]
Shimada, Yoshifumi [2 ]
Moriyama, Masato [1 ]
Wakai, Toshifumi [2 ]
Saijo, Yasuo [1 ]
机构：
[1] Niigata Univ, Dept Med Oncol, Niigata, Japan
[2] Niigata Univ, Div Digest & Gen Surg, Niigata, Japan
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.05.347
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P74-1
引用
收藏
页码：S541 / S541
页数：1
相关论文
共 50 条
  • [1] Binimetinib, encorafenib and cetuximab (BEACON Trial) combination therapy for patients with BRAF V600E-mutant metastatic colorectal cancer
    Shahjehan, F.
    Kamatham, S.
    Chandrasekharan, C.
    Kasi, P. M.
    [J]. DRUGS OF TODAY, 2019, 55 (11) : 683 - 693
  • [2] Safety of encorafenib, binimetinib, plus cetuximab for Japanese patients with BRAF V600E metastatic colorectal cancer
    Yamaguchi, Toshifumi
    Daisuke, Kotani
    Atsuo, Takashima
    Takeshi, Kato
    Toshiki, Masuishi
    Yoshito, Komatsu
    Manabu, Shiozawa
    Taito, Esaki
    Naoki, Izawa
    Shinji, Takeuchi
    Hideaki, Bando
    Satoru, Iwasa
    Hiroko, Hasegawa
    Taroh, Satoh
    Hiroya, Taniguchi
    Takayuki, Yoshino
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S479 - S479
  • [3] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
    Lieberman, Jeffrey A.
    Dosovitz, Simon M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (09): : 879 - 879
  • [4] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
    Roviello, Giandomenico
    D'Angelo, Alberto
    Petrioli, Roberto
    Roviello, Franco
    Cianchi, Fabio
    Nobili, Stefania
    Mini, Enrico
    Lavacchi, Daniele
    [J]. TRANSLATIONAL ONCOLOGY, 2020, 13 (09):
  • [5] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
    Kopetz, S.
    Grothey, A.
    Yaeger, R.
    Van Cutsem, E.
    Desai, J.
    Yoshino, T.
    Wasan, H.
    Ciardiello, F.
    Loupakis, F.
    Hong, Y. S.
    Steeghs, N.
    Guren, T. K.
    Arkenau, H. -T.
    Garcia-Alfonso, P.
    Pfeiffer, P.
    Orlov, S.
    Lonardi, S.
    Elez, E.
    Kim, T. -W.
    Schellens, J. H. M.
    Guo, C.
    Krishnan, A.
    Dekervel, J.
    Morris, V.
    Calvo Ferrandiz, A.
    Tarpgaard, L. S.
    Braun, M.
    Gollerkeri, A.
    Keir, C.
    Maharry, K.
    Pickard, M.
    Christy-Bittel, J.
    Anderson, L.
    Sandor, V.
    Tabernero, J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (17): : 1632 - 1643
  • [6] Pancreatitis After Treatment With Encorafenib, Binimetinib, and Cetuximab for BRAF V600E Mutation-Positive Colorectal Cancer
    Kureyama, Yuika
    Hanaoka, Yutaka
    Tomita, Daisuke
    Matoba, Shuichiro
    Kuroyanagi, Hiroya
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [7] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer Reply
    Gardner, Caleb
    Kleinman, Arthur
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (09): : 880 - 880
  • [8] Encorafenib, binimetinib and cetuximab combined therapy for patients with BRAFV600E mutant metastatic colorectal cancer
    Huijberts, Sanne C. F. A.
    van Geel, Robin M. J. M.
    Bernards, Rene
    Beijnen, Jos H.
    Steeghs, Neeltje
    [J]. FUTURE ONCOLOGY, 2020, 16 (06) : 161 - 174
  • [9] Encorafenib, binimetinib, and cetuximab in BRAF V600E–mutated colorectal cancer: an early post-marketing phase vigilance study
    Hidenori Sakata
    Maki Murase
    Takeshi Kato
    Kensei Yamaguchi
    Kenichi Sugihara
    Shigenobu Suzuki
    Takayuki Yoshino
    [J]. International Journal of Clinical Oncology, 2023, 28 : 139 - 144
  • [10] Encorafenib and cetuximab versus irinotecan/cetuximab or FOLFIRI/cetuximab in Chinese patients with BRAF V600E mutant metastatic colorectal cancer: The NAUTICAL CRC study.
    Wang, Xicheng
    Deng, Yanhong
    Zhang, Yanqiao
    Liu, Tianshu
    Yuan, Xianglin
    Yang, Jianwei
    Zhang, Tao
    Zang, Ai-min
    Liu, Yu
    Huang, Li
    Ye, Feng
    Zong, Hong
    Ba, Yi
    Klauck, Isabelle
    Vedovato, Jean-Claude
    Groc, Melanie
    Guo, Angela
    Shen, Lin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA3559 - LBA3559
12345